Kingdon Capital Management’s Array Biopharma Inc ARRY Stock Holding History

Kingdon Capital Management’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-96,380	Closed	-$4.46M	–	87
2019 Q2	$4.46M	Buy	+96,380	New	+$2.71M	0.44%	54
2019 Q1	–	Sell	-569,298	Closed	-$8.11M	–	82
2018 Q4	$8.11M	Buy	569,298 +23,587	+4%	+$358K	1.22%	31
2018 Q3	$8.29M	Buy	545,711 +820	+0.2%	+$12.6K	0.58%	64
2018 Q2	$9.14M	Buy	544,891 +378,815	+228%	+$6.03M	0.64%	58
2018 Q1	$2.71M	Buy	+166,076	New	+$2.66M	0.21%	89

Other funds holding ARRY

ASN

Advisory Services Network Atlanta, Georgia $8.83B AUM 38.5% 1-Year Est. Return

Kingdon Capital Management's ARRY Position: Q3 2019 in Review

Kingdon Capital Management sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 96,380 shares — an estimated $4.46M sold.

Kingdon Capital Management first reported a position in ARRY in Q1 2018 and held it in 5 quarters. The position peaked at $9.14M in Q2 2018. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

Kingdon Capital Management reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
Kingdon Capital Management sold 96,380 Array Biopharma Inc shares in Q3 2019, an estimated $4.46M.
Kingdon Capital Management first reported a position in Array Biopharma Inc in Q1 2018 and held it in 5 quarters.
Kingdon Capital Management's Array Biopharma Inc position peaked at $9.14M in Q2 2018.
1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Kingdon Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.